First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours.
Eur J Cancer
; 169: 135-145, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35567919
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Anemia
/
Kidney Neoplasms
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Etiology_studies
/
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Eur J Cancer
Year:
2022
Document type:
Article
Country of publication: